Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: Human papillomavirus-mediated carcinogenesis

Head and Face Medicine

Volumn 6, Issue 1, 2010, Pages

  Feller, Liviu ^a   Wood, Neil H ^a   Khammissa, Razia A G ^a   Lemmer, Johan ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; ISOLATION AND PURIFICATION; MOUTH TUMOR; OROPHARYNX TUMOR; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; REVIEW; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

MLCS; MLOWN;

EID: 77954555333     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-6-14     Document Type: Review

References (37)

1. Morin PJ, Trent JM, Collins FS, Vogelstein B. Cancer genetics. Harrisons principles of internal medicine 2005, 447-453. New York: Graw-Hill, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, 16.
2. Fenton RG, Longo DL. Cancer cell biology and angiogenesis. Harrisons principles of internal medicine 2005, 453-464. New York: Graw-Hill, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, 16.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
4. Vogelstein B, Kinzler KW. Cancer genes and the pathway they control. Nat Med 2004, 10:789-799. 10.1038/nm1087, 15286780.
5. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997, 386:761-763. 10.1038/386761a0, 9126728.
6. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649. 10.1038/25292, 9872311.
7. Levitt NC, Hickson ID. Caretaker tumour suppressor genes that defend genome integrity. Trends Mol Med 2002, 8:179-186. 10.1016/S1471-4914(02)02298-0, 11927276.
8. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007, 128:669-681. 10.1016/j.cell.2007.01.033, 17320505.
9. Burstein HJ, Schwartz RS. Molecular origins of cancer. N Engl J Med 2008, 358:527-511. 10.1056/NEJMe0800065, 18234758.
10. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007, 128:683-692. 10.1016/j.cell.2007.01.029, 17320506.
11. Wang SS, Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 2003, 31:35-40.
12. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999, 9:M57-60. 10.1016/S0962-8924(99)01661-X, 10611684.
13. Vinies P. Cancer as an evolutionary process at the cell level: an epidemiological perspective. Carcinogenesis 2003, 24:1-6. 10.1093/carcin/24.1.1, 12538342.
14. Breivic J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005, 15:51-60. 10.1016/j.semcancer.2004.09.008, 15613288.
15. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003, 63:6212-6220.
16. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005, 32S:S7-S15.
17. Miller CS. Pleiotrophic mechanisms of virus survival and persistence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100:527-536. 10.1016/j.tripleo.2005.03.017, 16243236.
18. von Knebel Doeberitz M. New markers for cervical dysplasia to visualize the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002, 38:2229-2242. 10.1016/S0959-8049(02)00462-8, 12441259.
19. Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 2002, 78:225-228. 10.1136/pmj.78.918.225, 1742321, 11930025.
20. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007, 107:S2-S5. 10.1016/j.ygyno.2007.07.067, 17938014.
21. Martin MP, Carrington M. Immunogenetics of viral infections. Curr Opin Immunol 2005, 17:510-516. 10.1016/j.coi.2005.07.012, 16084708.
22. Nghiem P, Kupper TS. Basal and squamous cell carcinomas. Principles of molecular medicine 1998, 65-72. Totowa New Jersey: Humana Press Inc, Jameson JL, 1.
23. Nguyen LQ, Jameson JL. The cell cycle. Principles of molecular medicine 1998, 65-72. Totowa New Jersey: Humana Press Inc, Jameson JL, 1.
24. Elgui de Oliveira D. DNA viruses in human cancer: An integral overview of fundamental mechanisms of viral oncogenesis. Cancer letters 2007, 247:182-196. 10.1016/j.canlet.2006.05.010, 16814460.
25. Longworth MS, Laminis LA. Pathogenesis of human papillomavirus in differentiating epithelia. Microbiol Mol Biol Rev 2004, 68:362-372. 10.1128/MMBR.68.2.362-372.2004, 419925, 15187189.
26. Watson RA, Thomas M, Banks L, Roberts S. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci 2003, 116:4925-4934. 10.1242/jcs.00809, 14625386.
27. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol 2003, 77:6957-6964. 10.1128/JVI.77.12.6957-6964.2003, 156174, 12768014.
28. Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol 2008, 56:509-557. full_text, 2149907, 18086422.
29. Jameson JL. Oncogenes and tumour suppressor genes. Principles of molecular medicine 1998, 73-82. Totowa New Jersey: Humana Press Inc, Jameson JL, 1.
30. Duensing S, Münger K. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 2003, 77:12331-12335. 10.1128/JVI.77.22.12331-12335.2003, 254291, 14581569.
31. Bonnez W. Papillomavirus. Clinical virology 2002, 557-596. Washington D.C.: ASM Press, Richman DD, Whitley RJ, Hayden FG, 2.
32. Campo MS. Animal models of papillomavirus pathogenesis. Virus Res 2002, 89:249-261. 10.1016/S0168-1702(02)00193-4, 12445664.
33. Palefsky J. Biology of HPV in HIV. Adv Dent Res 2006, 19:99-105. 10.1177/154407370601900120, 16672559.
34. Del Mistro A, Chieco Bianchi L. HPV related neoplasias in HIV-infected individuals. Eur J Cancer 2001, 37:1227-1235. 10.1016/S0959-8049(01)00107-1, 11423255.
35. Gillison ML. Human papillomavirus and prognosis of oropharyngealsquamous cell carcinoma: Implication for clinical research in head and neck cancer. J Clin Oncol 2006, 24:5623-5625. 10.1200/JCO.2006.07.1829, 17179099.
36. Fröhling S, Döjner H. Chromosomal abnormalities in cancer. N Engl J Med 2008, 359:722-734. 10.1056/NEJMra0803109, 18703475.
37. Albertson DC, Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 2003, 12(rev issue 2):R145-R152. 10.1093/hmg/ddg261, 12915456.